Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Top Cited Papers
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 67 (2) , 139-145
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant DepressionBiological Psychiatry, 2009
- Daily process methodology for measuring earlier antidepressant responseContemporary Clinical Trials, 2008
- Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions2007
- Continuation Electroconvulsive Therapy vs Pharmacotherapy for Relapse Prevention in Major DepressionArchives of General Psychiatry, 2006
- Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of AlcoholismNeuropsychopharmacology, 2006
- Two Case Studies of Patients with Major Depressive Disorder Given Low-Dose (Subanesthetic) Ketamine InfusionsPain Medicine, 2006
- Clinical and Sensorimotor Gating Effects of Ketamine in NormalsNeuropsychopharmacology, 2001
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)Journal of Traumatic Stress, 1998
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- The Brief Psychiatric Rating ScalePsychological Reports, 1962